Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1Phase 1/2 1

Status

Recruiting 2Active not recruiting 2Unknown 1

Sponsor Class

INDUSTRY 6OTHER 5NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Neoplasms 2Stomach Neoplasms 1Non-Small Cell Lung Cancer Metastatic 1Lung Neoplasms 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Carboplatin 330Pemetrexed 266Cisplatin 234Docetaxel 195Paclitaxel 182Radiotherapy 181Erlotinib Hydrochloride 153pembrolizumab 147Gemcitabine 147Bevacizumab 125Drug Therapy 121Radiosurgery 115Nivolumab 112osimertinib 92durvalumab 88Gefitinib 67atezolizumab 63Vinorelbine 63Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 54anlotinib 42Immunotherapy 42Taxes 39Blood Specimen Collection 39Ipilimumab 38130-nm albumin-bound paclitaxel 38Specimen Handling 36Immune Checkpoint Inhibitors 35Radiation 34Albumin-Bound Paclitaxel 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Non-Small-Cell Lung × tepotinib × Clear all
NCT07619339 2026-06-02

A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
16 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05782361 2026-04-24

POTENT

Institute of Cancer Research, United Kingdom

Phase 1 Active not recruiting
19 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06083857 2026-03-11

PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
3 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06908993 2025-12-17

COMET

Intergroupe Francophone de Cancerologie Thoracique

Phase 3 Recruiting
133 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04591431 2023-10-03

ROME

Fondazione per la Medicina Personalizzata

Phase 2 Unknown
400 enrolled
BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡